h1

navindexsubmissionagendafacultyprogramlakeregistrationnav

title

Thursday, September 13


3:00 PM                Registration

4:00 - 4:30            Welcome and Overview of Program

Kenneth Sherman, MD, PhD - University of Cincinnati

Session 1            Epidemiology and Scope of Disease
                             Moderator: TBA

4:30 – 5:00            HIV Transmission and Care Cascade 2018

TBA

5:00 – 5:30            HIV Treatment in 2018: When to Start, What to Start

TBA

5:30 – 6:00            ESLD and HCC in HIV-Infected Persons - Epidemiology

TBA

6:00 – 6:30            HIV and the Aging Liver  

TBA

6:30 – 6:45            Selected Abstract 

TBA

6:45 - 7:00           Selected Abstract  

TBA

7:00 – 9:00            Poster Reception (all poster presenters at posters), Cocktail Reception

Friday, September 14


7:00 - 7:30 AM      Continental Breakfast

Session 2             Pathophysiology and Immunobiology of Liver Disease in HIV-Infected Patients 
                              
Moderator:  

7:30 - 8:00             Mechanisms of Liver Injury Relevant to the HIV-infected Patient

TBA

8:00 - 8:25             Role of CCR5 and CCR2 in Liver Disease

TBA

8:25 – 8:50            Alcohol Mechanisms of Injury in HIV

TBA

8:50 – 9:10           The Microbiome in HIV 

TBA

9:10 - 9:25            Selected Abstract    
                              

                                    TBA

9:25 - 9:40            Selected Abstract 
                              

                              TBA

9:40 - 9:55           Selected Abstract 
                              

                                    TBA

9:55 - 10:30          Break

Session 3            Hepatitis B and HIV
                             Moderator: TBA 


10:30 – 11:00        New Targets for HBV Treatment

TBA

11:00 – 11:25        Immune Checkpoint Inhibitors for HBV: Taking the Plunge

TBA

11:25 - 11:55         HDV: Could/Should we Screen? If So, What Then

TBA

11:55 – 12:10       Selected Abstract 

TBA

12:10 – 12:25        Selected Abstract 

TBA 

12:25 – 12:55       HBV Vaccination: When it Doesn't Work

                                    TBA

12:55 – 1:00        Move to Small Group Area

                                    

1:00 – 2:00          Small Group Case-based Lunches with Experts (Groups of 10 or less meet in private dining)

Saturday, September 15


7:30 - 8:00 AM      Continental Breakfast

Session 4            Hepatitis C and HIV
                             Moderator: TBA 

8:00 - 8:30             Treatment of HCV/HIV Coinfected Patient

 TBA

8:30 - 9:00             HCV Vaccine: Fact of Fantasy

 TBA

9:00 - 9:15             HCV Elimination in HIV-Infected Patients  

 TBA

9:15 - 9:30             PANEL DISCUSSION 
 

9:30 - 9:45            Break

Session 5             NAFLD and NASH in HIV
                              Moderator: TBA

9:45 - 10:10         Diagnosis and Epidemiology of NSFLD/NASH in HIV

TBA

10:10 - 10:35        New Treatments for NAFLD/NASH

TBA

Session 6             Drugs and Alcohol in HIV and Hepatitis CoInfections
                              Moderator: TBA 

10:35 - 11:00         Alcohol Abuse in the HIV-Infected Population: Reversing the Trends

TBA

11:00 - 11:20          Harm Reduction and Treatment for HCV and Drug Use: What Works, What Doesn't

TBA

11:20 - 11:45           National and Local Policy: How it Impacts Infection, Reinfection and Cure of HCV and HIV

                              TBA

11:45 - 12:05           Modeling Harm Interventions to Prevent HCV and HIV Transmission

                              TBA

12:05 - 12:30           Psychiatric Comorbidities in HIV - How it Affects Treatment of HIV and Hepatitis

                              TBA

Session 7            Research Agenda - Plans for the Next Two Years
                             Moderator: TBA 

12:30 - 12:50           NIH Goals and Opportunities

                              TBA

12:50 - 1:10             Summary of Key Research Agenda Items

                                     Kenneth E. Sherman, MD, PhD - University of Cincinnati

 1:10 - 1:30              Conference Wrap-Up

                                  Kenneth E. Sherman, MD, PhD - University of Cincinnati

 *Agenda is tentative and subject to change.

Sponsored by University of Cincinnati
mer

Important Dates:

Registration opens - May 21
Abstract Submission opens - TBD
Housing Deadline - July 25

Faculty
Chair                                  
Kenneth E. Sherman, MD, PhD
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio

Organizing Committee  
Marion Peters, MD
Chief of Hepatology Research
University of California San Francisco
San Francisco, California 

David Thomas, MD, MPH
Chief, Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland